The Endocannabinoid System in Glial Cells and Their Profitable Interactions to Treat Epilepsy: Evidence from Animal Models
Open Access
- 8 December 2021
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (24) , 13231
Abstract
Epilepsy is one of the most common neurological conditions. Yearly, five million people are diagnosed with epileptic-related disorders. The neuroprotective and therapeutic effect of (endo)cannabinoid compounds has been extensively investigated in several models of epilepsy. Therefore, the study of specific cell-type-dependent mechanisms underlying cannabinoid effects is crucial to understanding epileptic disorders. It is estimated that about 100 billion neurons and a roughly equal number of glial cells co-exist in the human brain. The glial population is in charge of neuronal viability, and therefore, their participation in brain pathophysiology is crucial. Furthermore, glial malfunctioning occurs in a wide range of neurological disorders. However, little is known about the impact of the endocannabinoid system (ECS) regulation over glial cells, even less in pathological conditions such as epilepsy. In this review, we aim to compile the existing knowledge on the role of the ECS in different cell types, with a particular emphasis on glial cells and their impact on epilepsy. Thus, we propose that glial cells could be a novel target for cannabinoid agents for treating the etiology of epilepsy and managing seizure-like disorders.Keywords
Funding Information
- Eusko Jaurlaritza (IT1230-19)
- Ministerio de Economía y Competitividad (SAF2015-65034-R, PGC2018-093990-A-I00)
- Ministerio de Ciencia e Innovación (PID2019-107548RBI00)
- Instituto de Salud Carlos III (RD16/0017/0012)
This publication has 249 references indexed in Scilit:
- Cannabidiol protects oligodendrocyte progenitor cells from inflammation-induced apoptosis by attenuating endoplasmic reticulum stressCell Death & Disease, 2012
- Astrocytic regulation of glutamate homeostasis in epilepsyGlia, 2012
- The role of inflammation in epilepsyNature Reviews Neurology, 2010
- Cannabinoid and cannabinoid‐like receptors in microglia, astrocytes, and astrocytomasGlia, 2010
- Oligodendrocytes: biology and pathologyActa Neuropathologica, 2009
- The therapeutic potential of novel cannabinoid receptorsPharmacology & Therapeutics, 2009
- Temporal characterization of changes in hippocampal cannabinoid CB1 receptor expression following pilocarpine-induced status epilepticusBrain Research, 2009
- Endocannabinoid signaling in microglial cellsNeuropharmacology, 2009
- CB2receptors in the brain: role in central immune functionBritish Journal of Pharmacology, 2008
- The Endocannabinoid System Controls Key Epileptogenic Circuits in the HippocampusNeuron, 2006